UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549
                                  SCHEDULE l3D
                    Under the Securities Exchange Act of 1934
                               (Amendment No. 2)*


                            KINDRED HEALTHCARE, INC.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                     Common Stock, par value $0.25 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    494580103
--------------------------------------------------------------------------------
                                 (CUSIP Number)
                                                     with a copy to:
       Stephen Feinberg                              Robert G. Minion, Esq.
       450 Park Avenue                               Lowenstein Sandler PC
       28th Floor                                    65 Livingston Avenue
       New York, New York  10022                     Roseland, New Jersey  07068
       (212) 421-2600                                (973) 597-2424
--------------------------------------------------------------------------------
                 (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                 April 24, 2002
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule l3G to report
the  acquisition  that is the subject of this  Schedule 13D, and is filing  this
schedule because of Sections 240.13d-1(e),  240.13d-1(f) or 240.13d-1(g),  check
the following box.  [  ]

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits.  See Section 240.13d-7 for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).






Cusip No. 494580103
--------------------------------------------------------------------------------
  1)   Names of  Reporting Persons.  I.R.S. Identification Nos. of above persons
       (entities only):

                                Stephen Feinberg
--------------------------------------------------------------------------------
  2)   Check the Appropriate Box  if a Member of a Group  (See Instructions):
             (a)              Not
             (b)           Applicable

--------------------------------------------------------------------------------
  3)   SEC Use Only

--------------------------------------------------------------------------------
  4)   Source of Funds (See Instructions):    WC

--------------------------------------------------------------------------------
  5)   Check if  Disclosure of  Legal Proceedings is  Required Pursuant to Items
       2(d) or 2(e):           Not Applicable

--------------------------------------------------------------------------------
  6)   Citizenship or Place of Organization:     United States

--------------------------------------------------------------------------------
        Number of                        7) Sole Voting Power:            *
                                            ------------------------------------
        Shares Beneficially              8) Shared Voting Power:          *
                                            ------------------------------------
        Owned by
        Each Reporting                   9) Sole Dispositive Power:       *
                                            ------------------------------------
        Person With                     10) Shared Dispositive Power:     *
                                            ------------------------------------
--------------------------------------------------------------------------------
  11)  Aggregate Amount Beneficially Owned by Each Reporting Person:
                      941,421*

--------------------------------------------------------------------------------
  12)  Check if the  Aggregate Amount in Row (11)  Excludes Certain Shares  (See
       Instructions):        Not Applicable

--------------------------------------------------------------------------------
  13)  Percent of Class Represented by Amount in Row (11):      5.3%*

--------------------------------------------------------------------------------
  14)  Type of Reporting Person (See Instructions):     IA, IN

--------------------------------------------------------------------------------

*    Cerberus  Institutional  Partners, L.P.,  a  Delaware  limited  partnership
("Institutional"), is the holder of 195,624 shares of common stock ("Shares") of
Kindred  Healthcare,  Inc.  (the  "Company"),  Cerberus  International,  Ltd., a
corporation  organized under the laws of the Bahamas  ("International"),  is the
holder of  500,041  Shares  and  various  other  private  investment  funds (the
"Funds") own in the aggregate  245,756 Shares.  Stephen Feinberg  possesses sole
power to vote and direct the  disposition of all securities of the Company owned
by each of Institutional, International and the Funds. Thus, for the purposes of
Reg. Section  240.13d-3,  Stephen Feinberg is deemed to beneficially own 941,421
Shares,  or 5.3% of those deemed issued and outstanding.  See Item 5 for further
information.




Item 5.   Interest in Securities of the Issuer.
          ------------------------------------

          Based upon the Company's Proxy Statement  Pursuant to Section 14(a) of
the  Securities  Exchange Act of 1934 filed March 8, 2002,  as of March 7, 2002,
there were  17,682,917  Shares  issued and  outstanding.  As of April 24,  2002,
Institutional  is the holder of 195,624 Shares,  International  is the holder of
500,041 Shares and the Funds in the aggregate hold 245,756 Shares.  Mr. Feinberg
possesses sole power to vote and direct the disposition of all securities of the
Company owned by each of Institutional,  International and the Funds.  Thus, for
the  purposes  of  Reg.  Section  240.13d-3,   Stephen  Feinberg  is  deemed  to
beneficially own 941,421 Shares, or 5.3% of those deemed issued and outstanding.

          The following table  details the transactions since  the filing of the
Schedule  13D  Amendment  No.  1  by  Mr.  Feinberg  in  Shares,  or  securities
convertible into, exercisable for or exchangeable for Shares, by Mr. Feinberg or
any other person or entity  controlled  by him or any person or entity for which
he possesses voting or investment  control over the securities  thereof (each of
which were effected in an ordinary brokerage transaction):


                                I. Institutional
                                ----------------

                                   (Purchases)

                                      NONE

                                     (Sales)

            Date                     Quantity                     Price
            ----                     --------                     -----

        April 15, 2002                 6,500                     $45.76
        April 16, 2002                14,300                     $45.08
        April 17, 2002                 2,500                     $46.02
        April 24, 2002                17,300                     $45.41
        April 24, 2002                 8,300                     $45.24


                                II. International
                                -----------------

                                   (Purchases)

                                      NONE

                                     (Sales)

            Date                     Quantity                     Price
            ----                     --------                     -----

        April 15, 2002               11,400                      $45.76
        April 16, 2002               36,500                      $45.08
        April 17, 2002                6,400                      $46.02
        April 18, 2002                5,000                      $45.00
        April 24, 2002               44,000                      $45.41
        April 24, 2002               21,300                      $45.24




                                 III. The Funds
                                 --------------

                                   (Purchases)

                                      NONE

                                     (Sales)

            Date                     Quantity                     Price
            ----                     --------                     -----

        April 15, 2002                8,100                      $45.76
        April 16, 2002               17,700                      $45.08
        April 17, 2002                3,100                      $46.02
        April 24, 2002               21,700                      $45.41
        April 24, 2002               10,400                      $45.24






                                    Signature

            After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.

                                          August 21, 2002


                                          /s/ Stephen Feinberg
                                          --------------------------------------
                                          Stephen  Feinberg,  in   his  capacity
                                          as the investment manager for Cerberus
                                          Institutional Partners, L.P., Cerberus
                                          International, Ltd. and the Funds


      Attention: Intentional misstatements or omissions of fact constitute
                Federal criminal violations (See 18 U.S.C. 1001).